PECAM1 and glioblastoma: Next, the binding of these mAbs to CD45-CD31-CD90+GBM tumor cells in resected tissues from patients with GBM was examined using flow cytometry, and 506 mAbs that exhibited distinct binding to at least one resected tissue from patients with GBM [20] were selected.